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The presence of a patent infarct-related vessel at the time of 
hospital discharge has been shown to be one of the most 
important independent predictors oflate survival in patients 
with acute myocardial nfarction (1,2). However, the relation 
between vessel patency and postinfarction left ventricular 
remodeling is less understood. Previous tudies (J-5) have 
shown that, apart f om infarct size, the presence ofa patent 
infarct-r4ated artery is an important predictor f subsequent 
left ventricular dilation. However, these studies were per- 
formed in patients who did not receive thrombolytic herapy. 
Because thrombolytic herapy frequently causes reperfusion 
in the reversibly in_tured myocardium, probably limiting 
infarct size and left ventricular dysfunction, the course of 
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subsequent left t entricular ~emodeii~g 
addition, one of these stuciies e 
graphic measurements to assess 
stenosis of the infarct-related artery. 
The aim of the present study was to evaluate the relation 
between the severity of the residual narrowing ofthe infarct- 
related artery assessed by quantitative angiography aad 
changes in left ventricular voht e and function i  the year 
after a first anterior myocardial inf rction in patients who 
received early thrombolytic herapy. 
S 
Patient selection. Fat tted with the diagnosis of
a first acute myocardial infarction were considered. 
inclusion criteria we 
anterior myocardial I racte~st~c electrocar- 
ic (ECG) ST segment elevation and 
tion by characteristic creatine k ase 
vation; 2) patient recei 
bolytic treatment within 
(recombinant tissue-type p~asrn~~ogen activ
bolus injection of 10 mg, followed by an additional 50 rng 
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during 1 h and 40 mg during the next 2 h); 3) no contraindi- 
cations to thrombolytic therapy; and 4) significant disease 
present only in the left anterior descending coronary artery 
on coronary arteriography (patients with >50% diameter 
stenosis nvessels other than the infarct-related artery were 
excluded). 
Ttrr exclusion criteria were 1) history of previous myo- 
cat-dial infarction; 2) presence of significant valvular heart 
disease, cardiomyopathy or atria1 arrhythmias; 3) inadequate 
echocardiographic recordings; and 4) subsequent coronary 
intervention (for example, coronary bypass surgery o  an- 
gioplasty) before completion ofthe study protocol. 
protocol. Blood was sampled forserum creatine kinase 
immediately after admission, every 4 h over the next 24 h
and then every 8 to 12 h over the next 48 h. Peak serum 
creatine kinase was taken as the estimate of infarct size. 
Between 7 and 10 days after admission, all patients under- 
went coronary arteriography, echocardiography and radio- 
nuclide angiography. Echocardiographic and radionuclide 
studies were repeated at6 months and 1 year. All patients 
had given written informed consent for the study, which was 
approved by the Institutional Ethical Commiatee. 
Patients were considered to have acute (~24 h) reperfu- 
sion based on the fobving noninvasive clinical criteria 
(4-9): I) early peak creatine kinase level 112 h after the 
start of thrombulysis; 2) ~50% reduction in ST segment 
elevation 90 to 120 min after the start of thrombolysis; 
3) reperfusion arrhythmias within the 1st 90 min of throm- 
bolytic therapy; and 4) abrupt lessening ofchest pain after 
thrombolytic herapy. 
Echocardiography. Two-dimensional echocardiographic 
examination was performed by means of a Hewlett-Packard 
model 7702OA echocrrdiographic system with a 2.SMHz 
transducer. Left ventricular end-diastolic and end-systolic 
volumes were computed according tu an algorithm that 
related left ventricular volume to a hitlf-ellipsoid und half- 
cylinder geometry (IO). An apical four-chamber ventricular 
long-axis view and perpendicular mid-ventricular septum to 
lateral wall distance were used, assuming a circular left 
wmhdar cross-sectional configuration. End-diastole was 
defined as the fi’atne coincident with the onset of the QRS 
complex on the ECG and end-systole as the subsequent 
frame with the smallest ventricular cavity area. All volumes 
were normalized to body surface area. The examinations 
Were reviewed and analyzed by two independent observers. 
Concordance of analysis was achieved in 95% of cases. if 
discrepancies arose, these studies were reviewed and agree- 
ment was obtained. 
Radionuclide angiography. High temporal resolution 
radionuclide v ntricutography was performed with the pa- 
tient at rest in the supine position. Red blood cells were 
labeled invivo with 25 mCi of technetium-99m. Imaging was 
performed with a small field of view Anger camera equipped 
with a low energy, general purpose, parallel hole collimator 
oriented in the 45” left anterior oblique position, with a 15” 
caudal tilt. Data were acquired inframe mode by computer- 
based ECG gating, with 2x digital zoom. Ejection fraction 
was measured onthe raw time-activity curve by a standard 
technique and expressed as a percent (11). 
Cardiac at~~teriz~~on an 
qraphy. Selective coron 
with the percutaneous femo 
grams were obtained after the administration f mtracoro- 
nary nitroglycerin. Nitroglycerin was employed to minimize 
the effect of varying vasomotor tone on vessel lumen diam- 
eter. All angiograms were reviewed as 
by quantitative coronary arteriography. 
including craniai- and caudal-angulated 
for all patients. The infarct 
analysis of the acute BCC S 
regional wall motion abno two-dirne~~io~a~ 
echocardiography andthe 
Coronary cineangiographic films were analyzed by a 
previously described (12) computer-assisted edge de~tinn 
coronary quantitation system. End-diastolic ine frames that 
showed !he narrowest enotic diameter and clearly demon- 
strated the stenotic segment were selected and magnified 
(x4). Coronary segments were centered inthe i 
The image was digitized and then processed by an Epix 4 
Meg video processor board in a Hewlett-Packard host com- 
puter. The user was then asked to place several points along 
each edge of the segment to be measured. These points were 
used to guide the edge-searching process. The user-specified 
points were connected by a curve generated by cubic spline 
interpolation. At each point along this curve, a perpendicular 
line of 24 pixels centered on the CW. , was constructed. This 
line was perpendicular to nd centered on the edge of the 
coronary artery segment. The image was sampled at each 
point along the perpendicular line. These 24-pixel values 
form a brightness function that had a low value outside the 
opacified coronary artery and increased to a high value 
within the artery. The edge was defined by using an algo- 
rithm of the weighted sum of first and second erivatives of
the brightness function. Detected edges were presented to
the user for (optional) editing and approval. At no time was 
the length of an edited margin >20% of the total ength of the 
quantitated segment. Once the edges were approved, a
center line was constructed. The diameter was computed as 
the distance between the edges perpendicular to the center 
line. The diameter function was filtered by a Spoint median 
filter to remove artifacts occasionally introduced by unusual 
segment geometry. The user then indicated the segment 
fiducial (starting) and end points. The minimal lesion diam- 
eter was used for subsequent analysis. Catheters of known 
diameter were used for calibration (13). 
Patients were stratified into three groups according to 
whether the minimal lesion diameter was 0 (total occlusion), 
Cl.5 or 21.5 mm. 
Statisticd analysis. All data are expressed as mean value 
‘- SD unless otherwise stated. Analysis of variance was used 
to assess erial measurements a d the difTerences among 
groups. Correlations between variables were assessed using 
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aracreristics of the T@ree Patient Groups 
---- 
Group I Group II Group 111 
(total occlusion) (< 1.5~mm stenosis) (Il.5~mm stenosis) 
fn = 14) In = 24) (n = 20) 
Age WI 53? 10 56 i 9 48 + 7 
Male/female (no.) 1014 2113 1713 
Peak CK (U/liter) 2.645 2 1,452 2.214 + I.322 2.295 1.296 + 
Minimal lesion 0.0 f 0.0 0.9 + 0.4 1.7 0.6 + 
diameter (mm) 
EDVbdhn*) 74.3 c 8.5 40.5 +8.3 68.4 ? 7.9 
EN (ml/m?) 50.5 f 7.5 45.6 -e 8.1 42.7 i- 7.8 
Rest EF (%) 43.7 + 9.2 42.5 + 8.4 44.8 + 7.6 
CK = serum creatine kinase; EDV = left ventricular end-diastolic volume: EF = left ventricular ejection 
fraclion; ESV = left ventricular end-systolic volume. 
linear regression analysis a d Pearson’s correlation toe 
ultivariate r:Sression analysis was 
ncy of chang; in ieft ventricular vo 
lesion diameter and peak creatine kinase. 
considered significant w en the confidence limits were 
>95% (p < 0.05). 
). Of 66 patients initially 
enrolled in the study, 8 were subsequently excluded because 
4 died and 4 underwent either surgical coronary bypass or 
coronary angioplasty during the follow-up period. The final 
study group consisted of 58 patients, 48 men and 10 women 
with a mean age of 56 2 9 years. 
There were 14 patients in Group I (total occlusion), 24 in 
Group II (minimal lesion diameter <IS mm) and 20 in 
Group III (minimal lesion diameter >l.5 mm) 
lumen diameter was 0.9 t 0.4 mm in Group I 
0.6 mm in Group III. There were no significant differences in 
age, gender distribution, medications and hemodynamic 
variables among the three groups. Patients in Group I had a 
higher peak creatine kinase level than did the other groups, 
although the difference was not significant (Group 1,2,645 2 
,214 -I- 1,322 U/liter and Group 111, 
2,295 “_ 1,296 U/liter; = NS). No patient was taki 
zyme inhibitor during the s 
At baseline, there were no significant differences in left 
ventricular end-diastolic volume, end-systolic volume and 
ejection fraction among the three groups (Table I). Grou 
and Group 11 patients showed a progressive increase in 
ventricular end-diastolic and end-systolic volumes during 
the follow-up period. 
astolic me. In Group I, end-diastolic volume 
inc from 7 2 8.5 to 94.1 f 9.3 ml/m* at 6 months 
(p < 0.01) and to 104.2 + 10.1 ml/m* at I year (p < 0.01 vs. 
baseline and p < 0.01 vs 6 months). iin Group II, end- 
diasrolic volame increase from 70.5 + 8.3 to 79.6 + 
10.2 ml/m’ at 6 months (p = NS) and to 84.8 2 8.9 ml/m2 at 
I year (p < 0.01 vs. baseline and p < 3.02 vs. 6 months). 
However, there were no significant differences in end- 
diastolic volume in Group 111 at baseline (68.7 f 7.9 ml/m’), 
6 months (71.3 t 9.8 ml/m*) and 2 year (73.2 2 8.3 mVm2). 
Comparisons among groups revealed that Group 1 had a 
A 
- Group1 
- Group11 
- GroupIll 
I3 e 
- Groupl --e- Groupl 
Group II Groupll 
- Group Ill --a-- Group Ill 
. 
‘0 1 
* 
_ 501 Figure 1. Graphs howing the se- 
llO- 
rial changes in left ventricular loo- BO - 45 end-diastolic volume (EDV) (A), 
end-systolic volume (ESV) (B) -; go 40 
and ejection fraction (EF) (C) in =; 80- 
g 
1 so- 3 
the three study groups in the E z35 
I-year follow-up eriod. Data are g 70- $40- 
w 
expressed as the mean value + 
111 
30 
SEM. 
60 -
l ps 0.01 vs.Group II8 Ill 
30 - 
* p < 0.01 vs.Group II8 III 
50 - 
t p c 0.02 vs.Graup Ill t p c 0.05 vs.Group Ill 25 . p ~0.02~ GfoupllS Ill 
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Figure 2. Graphs howing percent changes inend-diastolic volume 
(EDV) (upper) and end-systolic volume (ESV) (lower) in the three 
study groups at 6 and 12 months after myocardial nfarction. Data 
are expressed asmean value rt SEM. 
significantly larger end-diastolic volume than that in Groups 
II and I11 at both 6 months and 1 year (6 months, 9;t.l -t 9.3 
vs. 79.6 + 10.2 and 71.3 + 9.8 ml/m*, respectively, p < 0.01; 
1 year, 104.2 % 10.1 vs. 84.8 1: 8.9 and 73.2 t 8.3 ml/m*, 
respectively, p < 0.01). Group II also had a significantly 
nd~y$to~~ volume. In Group I, end-systolic volume 
increased from 50.5 +7.5 to 59.1 C 8.7 ml/m* at 6 months 
(p < 0.02) and to 65.4 ? 7.4 ml/m* at I year (p < 0.01 vs. 
higher end-diastolic volume at 1 year compared with that in 
baseline and p < 0.02 vs. 6 months). In Group II, end- 
Group III (84.8 ” 8.9 vs. 73.2 2 8.3 ml/m*, p < 0.02) (Fig. 
systolic volume increased from 45.6 f 8.1 to 47.7 f 
8.8 ml/m2 at 6 months (p = NS) and to 50.2 + 7.1 ml/m* at 1 
year (p < 0.02 vs. baseline and p = NS vs. 6 months). 
IA). 
However, there were no significant differences in end- 
systolic volume in Group III at baseline (42.7 ? 7.8 ml/mz), 
6 months (39.4 2 7.9 ml/m’) and 1 year (40.3 + 8.3 ml/m*). 
Comparisons among roups revealed that Group 1 had a 
significantly larger end-systolic volume than did Groups II 
and III at both 6 months and i year (6 months, 59.1 + 8.7 vs. 
47.7 * 8.8 and 39.4 * 7.9 ml/m*, respectively, p < 0.01; 1 
year, 65.4 ? 7.4 vs. 50.2 ? 7.1 and 40.3 + 8.3 ml/m*, 
respectively, p < 0.01). Group II also had a significantly 
higher end-systolic volume at 1 year compared with that in 
Group III (50.2 -C 7.1 vs. 40.3 f 8.3 ml/m*, p < 0.05) (Fig 
1B). 
@xtlou fraction. Left ventricular ejection fraction in 
Group I decreased from 43.7 + 9.2% to 37.5 -C 8.7% at 6 
months (p = NS) and to 33.1 ?z 7.7% at I year (p < 0.01 vs. 
baseline), so that it was significantly ower than that of 
Groups II and III at 1 year (33.1 2 7.7% vs. 39.2 k 7.6% and 
46.4 It: 9.1%, respectively, p < 0.02). Ejection fraction in 
Groups II and III showed no significant serial changes (Fig. 
1C). Figure 2 shows the percent changes in end-diastolic 
volume and end-systoiic volume in the three groups at 6 and 
12 months. 
with or without 
end-diastolic volume and ejection fraction in all three 
al lesion diameter to 
In Figure 3, the percent change in left ventricular end- 
diastolic volume at 1 year was plotted against minimal lesion 
diameter. Although there was a significant linear relation 
between them (r = 0.66, p < O.OOl), the distribution of the 
data points suggested a nonlinear pattern. Accordingly, 
polynomial curve-fitting analysis was performed. Data 
points were best represented bya second egree polynomial 
ventricular e~d=dt~tol~~ volume (Pig. 3). The relation of 
function, with a correlation coefficient of0.77 (p < 0.001). 
minimal lesion diameter and peak creatine kinase (an esti- 
mation of infarct size) to the change in left ventricular 
volumes at I year was analyzed by multivariate r gression 
analysis. Both variables were found to be significant inde- 
pendent predictors ofend-diastolic volume change at I year 
(r = 0.71, p < 0.001). Of the two variables, minimal lesion 
diameter had a higher partial correlation coefficient (r = 
0.66, p < 0.001) than did peak creatine kinase (r = 0.38, p <: 
0.01). 
The present study showed that left ventricular dilation 
occurs after thrombolytic therapy in patients with acute 
anterior myocardial nfarction. The degree of left ventricular 
dilation is related to the severity of the residual stenosis of 
the infarct-related artery and is independent of final infarct 
size. This suggests hat he degree of continuing perfusion of
the infarct area is important for the subsequent left ventric- 
ular remodeling process even after early reperfusion. 
Infarct expauslon 
myocardii infarction. Left ventricular volume is a well 
recognized prognostic factor in patients recovering from 
myocardial nfarction (14). In fact, in patients with coronary 
artery disease, leftventricular volume, even more than the 
@Knup I Gmup HI Group III 
(total occlusion) (<1.5-mm steilosis) el.5-ml stenosis) 
tn = 14) (n = 24) (n = 20) 
No NO N9 
Weperfusion eperfusion Reperfusion Reperk&m Reperfusion Reperhision 
(n = 4) (n = 10) (n = 14) @-I = IO) (n = 13) (n = 7) 
ESV (mhZ) 
Baseline 49.4 2 7.9 50.9 -b 8.4 46.2 t 8.7 44.8 2 8.9 43.1 + 7.3 42.0 2 7.7 
; Months 60.2 + 9.1 58.7 + 7.8 47.1 d 8.7 48.5 k 8.3 38.6 2 8.9 40.9 + 8.2 
1 Year 64.2 r 8.6 B.S.9 I.! 8.2 40.6 + 8.9 51.0 ” 7.4 39.4 + 7.4 42.0 +- 8.7 
EDV (d.‘d) 
Bafzline 72.5 c 8.1 75.0 + 7.3 68.9 k 7.5 72.7 ?z 7.9 68.5 +- 8.5 69.1 ‘- 9.5 
6 Months 92.5 r 9.2 94.7 I? 8.8 80.2 z 8.4 78.8 t 9.0 70.5 ” 7.2 72.8 2 8.9 
1 Year 1022.7 -I- 8.7 104.8 ? 7.5 83.9 1 8.5 86.1 + 7.5 72.2 _e a.1 75.1 t 8.0 
EF (v/u) 
Baseline 44.5 ” 8.9 43 4 c 7.7 43.2 1- 8.4 41.5 rt 7.6 45.6 + 7.2 43.3 r 4.6 
6 Months 38.2 1: 7.9 37.2 r 7.6 39.8 ” 6.8 40.8 i: 8.9 44.5 2 8.5 46.5 +- 9.1 
1 Year 34.5 -_t 8.2 32.5 ” 9.3 3tr.2 + 8.1 40.6 9 7.3 45.3 I!- 8.9 48.4 rt 7.8 
Tl!ere were n,~ srgntncanr ditkrences belween patients with or without acute reperfusion for serial volumes and P jection hclion in all three groups. 
Abbreviations as in Table 1. 
extent ofcoronary artery disease, represents the most potent 
rdial infarction an 
expansion isaccompanied byregional 
trislalar shape and marked a~n~r~a~~ty of the t-related 
segment, leading to a significant increase in 1 ntricular 
ay et al. (20) developed a model of left 
ventricular remodeling after acute myocardial infarction. In 
this model, acute infarction i duces left ve~t~c~~ar systolic 
re 3. Plot of relation between minimal lesion diameter and 
percent change in left ventricular end-diastolic vohne (EBV) at I 
year in 33 patients. In view of the nonlinear appearance of the data 
points, a second-degree polynomial curve-fitting approach was 
used. 
y m 40.6 -34.0x + 7.21~~ 
r e 0.77 
p c 0.001 
0:5 1Ic.l 
, . I . . 
1.6 2.0 2.6 
inimal Lesien Diameter (mm) 
progress until the healing of injured myocardium increases 
the ability of the zone to resist wall stress. Bn nom~~farc~e~ 
provides the stimulus for voh.une 
t tends to return systolic and 
ai. These r~~o~e~i~~~ 
changes that occur in some patients after acW dial 
infarction result in an increase iw left ventricular and 
seem to be associated with he dynamic i~~rove~e~t, 
including lower Beft ventricular filling pressure and increased 
cardiac output. 
cry. Lamas et al. 
the characteristics of the ilmfarct-related 
vessel were important i  determining the severity of infarct 
and left ventricular distortion early after infarc- 
ients with severe l ft ventricular shape distortion, 
ce of a totally occluded infarct-related vessel at 
catheterization approximately 2 weeks after acute 
dial infarction was >80%. 
The presence 0fa pctent infarct-related vessel at the time 
of hospital discharge has been shown to be one of the most 
important independent predictors of late survival (1,X). Jer- 
emy et al. (4) found that left ventricular end-diastolic volume 
kcreased in patients without spontaneous rege 
~~~farct-related arteryand only rarely in patien 
taneous reperfusio . The only coronary anatoms 
of progressive l ft ventricular atiow was 83 ~cc~~~~d 
infarct-related vessel without co1 ral filling at the time of 
predischarge catheteaization, A similar fi 
r et al. (22). Patients with an occluded 
infarct-related vessel showed chronic left ve~~tr~cula~ en- 
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largement. In a study of serial changes in left ventricular 
volumes after thrombolytic therapy for acute myocardial 
infarction, Lavie et al. (231, also revealed that patients with 
a nonreperfused artery had greater left ventricular dilation 
than did patients with a reperfused artery. Blanke t al. (24) 
noted that spontaneous reperfusion of the infarct-related 
artery was associated with improved left ventricular func- 
tion. ~rcvious animal studies (2526) also showed that rela- 
tively late coronary reperfusion, performed after the time 
required to salvage significant quantities ofmyocardium, is 
associated with a decrease in wall thinning, dilation and 
aneurysm formation. The findings in the present study are 
consistent with these previous reports in showing that pa- 
tients with total occlusion have significantly more left ven- 
tricrllar dilation and reduced ejection fraction in the year 
after infarction. 
Correlation ofchange in left vent~~cu~~~ e~d.diaste~i~ vol- 
ume nnd severity of resldua! stenosis. The present study 
suggests that the degree of perfusion of the infarct-related 
artery after the initial insult is important in the process of 
continuing infarct expansion a d subsequent left ventricular 
dilation. The association between persistent occlusion of the 
left anterior descending artery and aneurysm formation i  
patients with anterior myocardial infarction (27) and the 
observations i  animal studies (26) that an unperfused infarct 
is more likely to expand than a perfused infarct are consis- 
tent with our findings. 
These observations suggest that perfusion f the infarct- 
related artery after the acute myocardial nsult may influence 
the myocardial infarct healing and remodeling processes. 
Improvement i  myocardial healing and preservation f an 
epicardial rim of tissue by continuing perfusion ofthe patent 
infarct-related artery may result in preserved left ventricular 
cavity size and avoidance of aneurysm formation (28). This 
may have multiple secondary beneficial effects, including 
less predisposition to arrhythmias, fewer thromboembolic 
complications of mural thrombus, decreased likelihood of 
cardiac rupture and improved diastolic and to a lesser extent 
systolic function by virtue of preservation f the cavity 
geometry. These effects may contribute to the improved 
survival observed in patients with a patent infarct-related 
vessel after infarction. 
Histologic differences between unperfused and reper- 
fused infarcts have been observed and this may be respon- 
sible for the difference inpropensity oventricular dilation. 
Absence of perfusion isassociated with coagulation necro- 
sis, whereas reperfusion causes contraction ba d necrosis 
(2% ConneUy et al. (30‘ lrggested hat he tensile strength of
unperfused and repefised infarct scars is different, although 
there is doubt as to whether this is significant a physiologic 
PRSSUreS. It is possible that reperfusion during the early 
healing phase may prevent the process of myocyte slippage 
and infarct hinning, which results in infarct expansion and 
may lead to continuing ventricular dilation. Another possi- 
bfi@ is that WerfUsion may prevent expansion and dilation 
by Preserving islands of epicardium. It may also be that he 
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diastolic properties of the infarct area or s~~o~~~ing iscb- 
emit myocardium ay be altered an favor ventricular 
dilation (31). 
The nonlinear relation between !efe ventricular end- 
diastolic volume change and minimal lesion diameter (Fig. 3) 
shows that left ventricular dilation decreases dramatically 
with an increase in minimal lesion diameter. Given tbe same 
infarct size, when the minimal lesion diameter is >I.5 mm, 
subsequent left ventricular dilation is minimal. Previous 
studies (31-33) have shown that minimal lumen di 
(either linear diameter or cross-sectional area) is i 
in predicting the functional impairment of the left 
associated with c~~~~a~~ ste osis. Tobis et al. (33 
that a minimal lesion diameter <I .5 mm in the pro 
anterior descending artery identified patients like1 
functional impairment during atrial pacing as assessea hy 
either global ejection fraction or segmental wall motion 
defects. Therefore, when the minimal diameter of the 
infarct-related artery is >I.5 mm, perfusion of the infarct 
area may be adequate, ven during periods of left ventricular 
stress. This may prevent subsequent left ventricular dilation. 
ole of therapy. edical therapies have recently been 
shown to reduce infarct expansion and left ventricular 
dilation after acute myocardial infarctior. Caphptopril has been 
shown to reduce ventricular dilation and mortality after 
experimental infarction in animals (34) and to decrease 
ventricular dilation in asymptomatic patients after acute 
ante%r myocardial nfarction (35). The effect of other drugs 
(for t;:;ample, nitrates and calcium channel blocking agents) 
on left ventricular dilation is not well established (36,37). 
ssive therapy (for exam- 
ple, angiotensin-converting enzyme inhibiting agents) hould 
be given to patients with an occluded vessel or severe 
residual stenosis after infarction to minimize subsequent left 
ventricular dilation. Whether coronary angioplasty orother 
interventional procedures should be performed to improve 
perfusion of the infarct-related vessel to minimize left ven- 
tricular dilation remains to be addressed by future studies. 
An appropriate patient study group would be those patients 
with acute myocardial infarction who have variable degrees 
of residual stenosis after early treatment with angioplasty. 
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